Inhibitory effect of yellow myrobalan (Terminalia chebula) extract on fibrosis induced by carbon tetrachloride in rat liver

Food Science and Biotechnology

Volumn 22, Issue 3, 2013, Pages 871-880

  Koo, Yun Chang ^a   Hong, Chung Oui ^a   Nam, Mi Hyun ^a   Kim, Ji Hoon ^a   Yang, Sung Yong ^a   Won, Nam Hee ^b   Park, Tae Sun ^c   Lee, Kwang Won ^a  

^a Korea University   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Yonsei University   (South Korea)

Author keywords

carbon tetrachloride; chebulic acid; liver fibrosis; Terminalia chebula

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HEPATIC STELLATE CELLS; INFLAMMATORY REACTION; LIVER FIBROSIS; PROTEIN PRODUCTION; SMOOTH MUSCLE ACTINS; TERMINALIA CHEBULA;

AMINO ACIDS; CARBON TETRACHLORIDE; GENE EXPRESSION;

PROTEINS;

EID: 84879680402     PISSN: 12267708     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10068-013-0158-x     Document Type: Article

References (38)

1. Pinzani M, Marra F. Cytokine receptors and signaling in hepatic stellate cells. Semin. Liver Dis. 21: 397-416 (2001).
2. Friedman SL. Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. New Engl. J. Med. 328: 1828-1835 (1993).
3. Parsons CJ, Takashima M, Rippe RA. Molecular mechanisms of hepatic fibrogenesis. J. Gastroen. Hepatol. 22(Suppl 1): S79-S84 (2007).
4. Rockey DC. Antifibrotic therapy in chronic liver disease. Clin. Gastroenterol. H. 3: 95-107 (2005).
5. Kisseleva T, Brenner DA. Role of hepatic stellate cells in fibrogenesis and the reversal of fibrosis. J. Gastroen. Hepatol. 22(Suppl 1): S73-S78 (2007).
6. Vera M, Nieto N. Hepatic stellate cells and alcoholic liver disease. Rev. Esp. Enferm. Dig. 98: 674-684 (2006).
7. Starkel P, Leclercq IA. Animal models for the study of hepatic fibrosis. Best Pract. Res. Cl. Ga. 25: 319-333 (2011).
8. Recknagel RO, Glende EA Jr, Dolak JA, Waller RL. Mechanisms of carbon tetrachloride toxicity. Pharmacol. Therapeut. 43: 139-154 (1989).
9. Kirtikar KR, Basu BD. Terminalia chebula. Vol. 1, pp. 1020-1023. In: Indian Medicinal Plants. Lalit Mohan Basu Publications, Allahabad, India (1935).
10. Lee HS, Cho HY, Park KW, Kim IH, Kim JT, Nam MH, Lee KW. Inhibitory effects of Terminalia chebula extract on glycation and endothelial cell adhesion. Planta Med. 77: 1060-1067 (2011).
11. Lee HS, Won NH, Kim KH, Lee H, Jun W, Lee KW. Antioxidant effects of aqueous extract of Terminalia chebula in vivo and in vitro. Biol. Pharm. Bull. 28: 1639-1644 (2005).
12. Lee HS, Koo YC, Suh HJ, Kim KY, Lee KW. Preventive effects of chebulic acid isolated from Termialia chebula on advanced glycation endproduct-induced endothelial cell dysfunction. J. Ethnopharmacol. 131: 567-574 (2010).
13. Grover IS, Bala S. Antimutagenic activity of Terminalia chebula (myroblan) in Salmonella typhimurium. Indian J. Exp. Biol. 30: 339-341 (1992).
14. Lee HS, Jung SH, Yun BS, Lee KW. Isolation of chebulic acid from Terminalia chebula retz. and its antioxidant effect in isolated rat hepatocytes. Arch. Toxicol. 81: 211-218 (2007).
15. Buege JA, Aust SD. Microsomal lipid peroxidation. Method. Enzymol. 52: 302-310 (1978).
16. Anderson ME. Determination of glutathione and glutathione disulfide in biological samples. Method. Enzymol. 113: 548-555 (1985).
17. Habig WH, Jakoby WB. Assays for differentiation of glutathione Stransferases. Method. Enzymol. 77: 398-405 (1981).
18. Flohe L, Gunzler WA. Assays of glutathione-peroxidase. Method. Enzymol. 105: 114-121 (1984).
19. Smith IK, Vierheller TL, Thorne CA. Assay of glutathionereductase in crude tissue-homogenates using 5, 5′-dithiobis(2-nitrobenzoic acid). Anal. Biochem. 175: 408-413 (1988).
20. Reitman S, Frankel S. A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am. J. Clin. Pathol. 28: 56-63 (1957).
21. Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J. 22: 659-661 (2008).
22. Kim JH, Koo YC, Hong CO, Yang SY, Jun W, Lee KW. Mutagenicity and oral toxicity studies of Terminalia chebula. Phytother. Res. 26: 39-47 (2011).
23. Sasaki Y. Does oxidative stress participate in the development of hepatocellular carcinoma? J. Gastroenterol. 41: 1135-1148 (2006).
24. Pastore A, Federici G, Bertini E, Piemonte F. Analysis of glutathione: Implication in redox and detoxification. Clin. Chim. Acta 333: 19-39 (2003).
25. Jurczuk M, Moniuszko-Jakoniuk J, Rogalska J. Glutathione-related enzyme activity in liver and kidney of rats exposed to cadmium and ethanol. Pol. J. Environ. Stud. 15: 861-868 (2006).
26. Ponnusankar S, Pandit S, Venkatesh M, Bandyopadhyay A, Mukherjee PK. Cytochrome P450 inhibition assay for standardized extract of Terminalia chebula retz. Phytother. Res. 25: 151-154 (2011).
27. Lee KS, Lee SJ, Park HJ, Chung JP, Han KH, Chon CY, Lee SI, Moon YM. Oxidative stress effect on the activation of hepatic stellate cells. Yonsei Med. J. 42: 1-8 (2001).
28. Zhan Y, Wang Y, Wei L, Chen H. Effects of vitamin E on the proliferation and collagen synthesis of rat hepatic stellate cells treated with IL-2 or TNF-α. Chinese Med. J. -Peking 116: 472-474 (2003).
29. Pereira-Filho G, Ferreira C, Schwengber A, Marroni C, Zettler C, Marroni N. Role of N-acetylcysteine on fibrosis and oxidative stress in cirrhotic rats. Arq. Gastroenterol. 45: 156-162 (2008).
30. Tipoe GL, Leung TM, Liong EC, Lau TY, Fung ML, Nanji AA. Epigallocatechin-3-gallate (EGCG) reduces liver inflammation, oxidative stress, and fibrosis in carbon tetrachloride (CCl4)-induced liver injury in mice. Toxicology 273: 45-52 (2010).
31. Park O, Jeong WI, Wang L, Wang H, Lian ZX, Gershwin ME, Gao B. Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride. Hepatology 49: 1683-1694 (2009).
32. Baeck C, Wehr A, Karlmark KR, Heymann F, Vucur M, Gassler N, Huss S, Klussmann S, Eulberg D, Luedde T, Trautwein C, Tacke F. Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury. Gut 61: 416-426 (2012).
33. Kumar Rajagopal S, Manickam P, Periyasamy V, Namasivayam N. Activity of Cassia auriculata leaf extract in rats with alcoholic liver injury. J. Nutr. Biochem. 14: 452-458 (2003).
34. Tacke F, Luedde T, Trautwein C. Inflammatory pathways in liver homeostasis and liver injury. Clin. Rev. Allerg. Immu. 36: 4-12 (2009).
35. Zhen MC, Wang Q, Huang XH, Cao LQ, Chen XL, Sun K, Liu YJ, Li W, Zhang LJ. Green tea polyphenol epigallocatechin-3-gallate inhibits oxidative damage and preventive effects on carbon tetrachloride-induced hepatic fibrosis. J. Nutr. Biochem. 18: 795-805 (2007).
36. Gressner AM. The cell biology of liver fibrogenesis - An imbalance of proliferation, growth arrest, and apoptosis of myofibroblasts. Cell Tissue Res. 292: 447-452 (1998).
37. Arthur MJ. Degradation of matrix proteins in liver fibrosis. Pathol. Res. Pract. 190: 825-833 (1994).
38. Milani S, Herbst H, Schuppan D, Surrenti C, Riecken EO, Stein H. Cellular localization of type I III and IV procollagen gene transcripts in normal and fibrotic human liver. Am. J. Pathol. 137: 59-70 (1990).